Milestone PharmaceuticalsMIST
13F holders, Q1 2024 (March 31)43holders
2famous investors
$1.80avg. 13F price*
At the end of Q1 2024, 43 institutions reported holding Milestone Pharmaceuticals Inc. (MIST) in their 13F filings. The largest holders were BlackRock Inc. ($8.9M), RTW Investments, LP ($5.8M) and Millennium Management ($5.1M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Milestone Pharmaceuticals Inc.
- CUSIP
- 59935V107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $14.8M |
| Exits | 7 | $1.7M |
Ownership 43 holders
| BlackRock Inc. | 0.00% | Add +52.0% | 4,971,344 | $8.9M |
| RTW Investments, LP | 0.09% | No change | 3,256,102 | $5.8M |
| Millennium Management | 0.00% | Add +91.1% | 2,855,612 | $5.1M |
| Alta Fundamental Advisers LLC | 2.15% | Add +41.9% | 2,371,289 | $4.2M |
| Lion Point Capital, LP | 7.98% | Add +39.4% | 2,300,207 | $4.1M |
| Citadel Advisors | 0.00% | Add +867.4% | 2,272,404 | $4.1M |
| Orbimed Advisors LLC | 0.07% | New | 2,000,000 | $3.6M |
| Nantahala Capital Management, LLC | 0.31% | New | 1,750,000 | $3.1M |
| Stonepine Capital Management, LLC | 2.08% | New | 1,462,296 | $2.6M |
| Goldman Sachs Group Inc. | 0.00% | No change | 1,353,067 | $2.4M |
| Bleichroeder LP | 0.59% | No change | 1,326,085 | $2.4M |
| Altium Capital Management LLC | 0.98% | New | 1,212,882 | $2.2M |
| Morgan Stanley | 0.00% | Add +18.9% | 819,828 | $1.5M |
| Velan Capital Investment Management LP | 0.63% | New | 650,000 | $1.2M |
| BML Capital Management, LLC | 0.73% | Add +37.0% | 606,145 | $1.1M |
| Monashee Investment Management LLC | 0.11% | New | 500,000 | $895K |
| Ikarian Capital, LLC | 0.23% | Add +0.7% | 466,019 | $834K |
| Bank of Montreal | 0.00% | New | 273,100 | $787K |
| Boxer Capital, LLC | 0.03% | No change | 309,007 | $553K |
| ADAR1 Capital Management, LLC | 0.10% | New | 202,460 | $362K |
| Ancora Advisors LLC | 0.00% | Add +20.0% | 60,000 | $107K |
| Envestnet Asset Management Inc. | 0.00% | Add +150.8% | 51,833 | $93K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -46.5% | 39,450 | $71K |
| Boothbay Fund Management, LLC | 0.00% | Add +11.6% | 30,779 | $55K |
| Northern Trust Corp. | 0.00% | Reduce -11.4% | 28,316 | $51K |
| Clear Creek Financial Management, LLC | 0.01% | Reduce -21.3% | 25,000 | $45K |
| State Street Corp. | 0.00% | Reduce -12.4% | 18,923 | $34K |
| Geode Capital Management, LLC | 0.00% | No change | 17,576 | $31K |
| Cetera Investment Advisers | 0.00% | New | 17,427 | $31K |
| BNP Paribas Financial Markets | 0.00% | Add +177.1% | 16,900 | $30K |
| Beta Wealth Group, Inc. | 0.01% | No change | 14,127 | $25K |
| XTX Topco Ltd | 0.00% | New | 13,403 | $24K |
| Creative Planning | 0.00% | No change | 13,080 | $23K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 10,500 | $19K |
| Valeo Financial Advisors, LLC | 0.00% | No change | 10,000 | $17K |
| National Bank of Canada | 0.00% | Add +84.4% | 7,100 | $12K |
| Osaic Holdings, Inc. | 0.00% | Reduce -57.3% | 6,000 | $11K |
| UBS Group AG | 0.00% | New | 2,618 | $5K |
| ICA Group Wealth Management, LLC | 0.00% | No change | 200 | $358 |
| Qube Research & Technologies Ltd | 0.00% | No change | 194 | $347 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 100 | $179 |
| Barclays PLC | 0.00% | Reduce -100.0% | 100 | $179 |
| Simplex Trading, LLC | 0.00% | Reduce -56.0% | 478 | $0 |
"% of holder's portfolio" is MIST's weight in each manager's 13F, not the share of Milestone Pharmaceuticals Inc. the manager owns.